A kind of drug for inhibiting brain tumor and its application

A drug and glioma technology, applied in the field of medicine, can solve problems such as limited use, limited application of temozolomide, and depression of users, and achieve the effect of reducing toxic and side effects, reducing toxic and side effects, and enhancing anti-tumor effects

Active Publication Date: 2021-08-06
LVCHAN BIOTECHNOLOGY CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Temozolomide (TMZ) is a first-line clinical chemotherapy drug for the treatment of glioma, but due to the emergence of drug resistance, its clinical use is limited, and in clinical practice, Temozolomide has prominent side effects, that is, users will have Nausea, vomiting, and listless reactions, which also limit the application of temozolomide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of drug for inhibiting brain tumor and its application
  • A kind of drug for inhibiting brain tumor and its application
  • A kind of drug for inhibiting brain tumor and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] A drug for inhibiting brain tumors, which is a TRPV4 agonist. The TRPV4 agonist can promote the influx of calcium ions in the TRPV4 signaling channel, thereby promoting the induction of autophagy in brain tumor cells and achieving a stronger anti-brain tumor effect. The dosage of TRPV4 agonist is: the concentration is 0.01 μM-30 μM, such as 0.01 μM, 0.05 μM, 0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM, 15 μM, 20 μM, 25 μM, 30 μM, etc.

[0039] In order to prove that TRPV4 agonists can inhibit brain tumors, the inventors conducted bioinformatics analysis on TRPV4 gene in normal brain tissue and glioma tissue. Download the GSE50161 data set from the gene expression database of the NCBI website, download the glioma-related database in TCGA from the UCSC gene expression database, and compare the glioma tissue microarray data in each data set. The data have passed quality control and homogenization. , the downloaded data were analyzed by using Graphpad Prism 7 software to analyze the...

Embodiment 2

[0042] On the basis of Example 1, the TRPV4 agonist is cannabidiol, and the concentration of the cannabidiol is 0.01 μM-30 μM, such as 0.01 μM, 0.05 μM, 0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM, 15μM, 20μM, 25μM, 30μM, etc.

[0043] We performed mechanistic studies on the role of cannabidiol in glioma, a typical representative of brain tumors, such as Figure 12-Figure 15 As shown, the effect of cannabidiol on glioma cell lines U251, U87, LN18, U118MG, and A172 cells was detected by MTT method, and the results showed that the inhibitory concentration of cannabidiol on glioma cell lines was IC 50 The range was 20-30 μM, and the effect of cannabidiol on primary glial cells was much lower than that of other tumor cell lines, indicating that the effect on normal cells was relatively small. In addition, the effect of cannabidiol on the clonal proliferation ability of glioma was evaluated by 3D colony formation experiment. The results showed that cannabidiol can significantly inhibit the ...

Embodiment 3

[0053] A drug for inhibiting brain tumors, which includes a TRPV4 agonist and a tumor suppressor with anti-tumor activity. The concentration ratio of the TRPV4 agonist and the tumor suppressor is (that is, the case where the two concentration units are the same in the same solution): (10-30): (10-500). The mechanism of action of the TRPV4 agonist is combined with the inhibitory mechanism of the tumor inhibitor, and the combination of the two achieves the anti-tumor effect of increasing efficiency and reducing toxic and side effects.

[0054] In this embodiment, any one or more TRPV4 agonists can be used in combination with any one or more tumor suppressors.

[0055] Preferably, the tumor suppressor comprises temozolomide. The temozolomide may be used in combination with at least one TRPV4 agonist.

[0056] Preferably, the TRPV4 agonist includes cannabidiol. The TRPV4 agonist cannabidiol can be used in combination with at least one tumor suppressor.

[0057] Optimally, if t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The application provides a drug for inhibiting brain tumors and its application. Wherein, the drug for inhibiting brain tumors includes at least one TRPV4 agonist capable of promoting calcium ion influx of TRPV4 signaling channel. The medicine provided by the application has a good therapeutic effect on brain tumors and related diseases, and has good application prospects for the treatment of brain tumors and related diseases. The medicine provided by the application is applied to medicines for treating brain tumors and related diseases, which can reduce the toxic and side effects produced in the clinical treatment of brain tumors and related diseases, and improve the therapeutic effect of brain tumors and related diseases.

Description

technical field [0001] The application relates to the technical field of medicine, in particular to a drug for inhibiting brain tumors and its application. Background technique [0002] Brain tumors refer to new organisms growing in the cranial cavity, also known as intracranial tumors and brain cancers, which can originate from the brain, meninges, nerves, blood vessels, and brain appendages, or form by metastasizing from other tissues or organs of the body into the brain , Most of them can produce headache, intracranial hypertension and focal symptoms, including brain tumors and brain metastases. Here, glioma is taken as an example. [0003] Glioma is one of the most common malignant brain tumors. The benign glioma grows slowly and has a long course of disease. The average time from the onset of symptoms to seeing a doctor is two years. The malignant tumor grows quickly and the course of the disease is short. Most of them are within 3 months from the onset of symptoms to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/05A61K31/4188A61K45/06A61K31/045A61P35/00A61P35/04A61P25/00A61P25/08
CPCA61K31/05A61K31/4188A61K45/06A61K31/045A61P35/00A61P35/04A61P25/00A61P25/08A61K2300/00
Inventor 黄腾飞
Owner LVCHAN BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap